SEARCH

SEARCH BY CITATION

References

  • 1
    Min DI, Monaco AP. Complications associated with immunosuppressive therapy and their management. Pharmacotherapy 1991; 11: 119S125S.
  • 2
    Starzl TE, Marchiaro TL, Rifkind D, Fotino M, Sternzel KH, Rubin AL. Factors in successful renal transplantation. Surgery 1964; 56: 296318.
  • 3
    Ekstrand A, Ahonen J, Gronhagen-Riska C, Groop L. Mechanisms of insulin resistance after kidney transplantation. Transplantation 1989; 48: 563568.
  • 4
    Rao M, Jacob CK, Shastry JC. Post-renal transplant diabetes mellitus—a retrospective study. Nephro-Dial-Transplant. 1992; 7: 10391042.
  • 5
    Ost L, Tyden G, Fehrman I. Impaired glucose tolerance in cyclosporine-prednisolone treated renal graft recipients. Transplantation 1988; 46: 370372.
  • 6
    Ekstrand AV, Eriksson JG, Gronhagen-Riska C, Ahonen PJ, Groop LC. Insulin resistance and insulin deficiency in the pathogenesis of posttransplantation diabetes in man. Transplantation 1992; 53: 563569.
  • 7
    Wahlstrom HE, Cooper J, Gores G, Rosen C, Wiesner R, Krom RAF. Survival after liver transplantation in diabetics. Transplant Proc 1991; 23: 15651566.
  • 8
    Tabasco-Minguillan J, Mieles L, Carroll P, Gavaler J, Van Thiel DH, Starzl TE. Long-term insulin requirement after liver transplantation with FK 506 in American veterans. Transplant Proc 1993; 25: 677678.
  • 9
    Mieles L, Gordon RD, Mintz D, Taussaint RM, Imventarza O, Starzl TE. Glycemia and insulin need following FK506 rescue therapy in liver transplant recipients. Transplant Proc 1991; 23: 949953.
  • 10
    Alessiani M, Cillo U, Fung JJ, Irish W, Abu-Elmagd D, Jain A, et al. Adverse effects of FK 506 overdosage after liver transplantation. Transplant Proc 1993; 25: 628634.
  • 11
    Levy MF, Husberg BS, Goldstein RM, Backman L, McMillan RW, Gibbs JF, et al. Diabetes mellitus and liver transplantation [Abstract]. Hepatology 1992; 16(suppl): 50A.
  • 12
    Krentz AJ, Dousset B, Mayer D, McMaster P, Buckels J, Cramb R, et al. Metabolic effects of cyclosporine and FK506 in liver transplant recipients. Diabetes 1993; 42: 17531759.
  • 13
    Dresner LS, Andersen DK, Kahng KU, Munshi IA, Wait RB. Effects of cyclosporine no glucose metabolism. Surgery 1989; 106: 163169.
  • 14
    Yamamoto H, Akazawa S, Yamaguchi Y, Yokota A, Yamasaki H, Nakanishi T, et al. Effects of cyclosporine A and low dosages of steroid on post transplantation diabetes in kidney transplant recipients. Diabetes Care 1991; 14: 867870.
  • 15
    Mitsuo M, Nakai I, Nakaji K, Arakawa K, Yasamura T, Omori Y, et al. Problems and management in kidney transplant recipients with impaired glucose metabolism. Nippon Geka Gakkai Zasshi 1992; 93: 993996.
  • 16
    Krentz A, Dmitrewski J, Mayer D, McMaster P, Buckels J, Dousset B, et al. Postoperative glucose metabolism in liver transplant recipients: a two-year prospective randomized study of cyclosporine versus FK506. Transplantation 1994; 57: 16661669.
  • 17
    Rao KV, Andersen RC. The impact of diabetes on vascular complications following cadaver renal transplantation. Transplantation 1987; 43: 193197.
  • 18
    Trail KC, Stratta RS, Larsen JL, Ruby EI, Patil KD, Langnas AN, et al. Results of liver transplantation in diabetic recipients. Surgery 1993; 114: 650658.
  • 19
    National Diabetes Data Group. Classifications and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 10391057.
  • 20
    Castaldo P, Stratta RJ, Wood RP, Markin RS, Patil KD, Shaefer MS, et al. Clinical spectrum of fungal infections after orthotopic liver transplantation. Arch Surg 1991; 126: 149156.
  • 21
    Markin RS, Stratta RJ, Wood RP. Infection after liver transplantation. Am J Surg Pathol 1990; 14(suppl): 6478.
  • 22
    Stratta RJ, Shaefer MS, Cushing KA, Markin RS, Reed EC, Langnas AN, et al. A randomized prospective trial of acyclovir and immunoglobulin prophylaxis in liver transplant recipients receiving OKT3 therapy. Arch Surg 1992; 127: 5564.
  • 23
    Jindal RM. Posttransplant diabetes mellitus—a review. Transplantation 1994; 58: 12891298.
  • 24
    Sumrani NB, Delaney V, Ding Z, Davis R, Daskalakis P, Friedman EA, Butt HM, et al. Diabetes mellitus after renal transplantation in the cyclosporine era—an analysis or risk factors. Transplantation 1991; 51: 343347.
  • 25
    Mejia G, Arbelaez M, Henao JE, Arango JL, Garcia A. Cyclosporine induced diabetes mellitus in renal transplants. Clin Transplant 1989; 3: 260263.
  • 26
    Roth D, Milgrom M, Esquenazi V, Fuller L, Burke G, Miller J. Posttransplant hyperglycemia. Increased incidence in cyclosporine-treated renal allograft recipients. Transplantation. 1989; 47: 278281.
  • 27
    Anguito M, Arizon JM, Valles FA, Mantero JA, Sancho M, Bueno G, et al. Influence on survival after heart transplantation of contraindicators seen in transplant recipients. J Heart-Lung Transplant 1992; 11: 708715.
  • 28
    Munoz E, Lonquist JL, Radovancevic B, Baldwin RT, Ford S, Duncan JM, Frazier OH. Long-term results in diabetic patients undergoing heart transplantation. J-Heart-Lung Transplant. 1992; 11: 943949.
  • 29
    Mora NP, Gonwa TA, Goldstein RM, Husberg BS, Klintmalm JB. Risk of post-operative infection after liver transplantation: a univariate and stepwise logistic regression analysis of risk factors in 150 consecutive patients. Clin Trans. 1992; 46: 443449.
  • 30
    Kusne S, Dummer JS, Singh N, Iwatsuki S, Makowka L, Esquivel C, et al. Infections after liver transplantation. Medicine 1988; 67: 132143.
  • 31
    Bagdade JD, Root RK, Bulger RJ. Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes 1974; 23: 915.
  • 32
    Jones RL, Peterson CM. Hematologic alterations in diabetes mellitus. Am J Med 1981; 70: 339352.